Intec Pharma Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website
(firmenpresse) - JERUSALEM, ISRAEL -- (Marketwired) -- 03/14/16 -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced today that its annual report on Form 20-F, containing audited financial statements for the year ended December 31, 2015, as filed with the Securities and Exchange Commission on March 14, 2016, is available through its website (). Shareholders may receive a hard copy of the annual report free of charge upon request to the Company.
Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The Company's product pipeline currently includes three product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, or AP-CDLD, which is being developed for the indication of treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients, Accordion Pill Zaleplon, or AP-ZP, which is being developed for the indication of treatment of insomnia, including sleep induction and the improvement of sleep maintenance, and an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers.
Zeev Weiss
Chief Executive Officer
(+972) (2) 586-4657
PCG Advisory
Vivian Cervantes
Managing Director
Phone (+1) 212 554-5482
Sean Leous
Managing Director
Phone (+1) 646 863-8998
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.03.2016 - 11:30 Uhr
Sprache: Deutsch
News-ID 457108
Anzahl Zeichen: 0
contact information:
Town:
JERUSALEM, ISRAEL
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 157 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Intec Pharma Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website"
steht unter der journalistisch-redaktionellen Verantwortung von
Intec Pharma Ltd. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
